Wall Street Journal - Sept 30
Sept 30 (Reuters) -The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy.
- Major hedge-fund investor Glenview Capital Management will meet top executives of CVS Health CVS.N on Monday to propose ways the struggling healthcare company can improve its operations.
- California Governor Gavin Newsom has vetoed a hotly contested artificial-intelligence safety bill after the tech industry raised objections, saying it could drive AI companies from the state and hinder innovation.
- NIO China secured an investment of 13.3 billion yuan ($1.90 billion) from its parent NIO 9866.HK and a group of strategic investors.
- U.S. suspects Rio Tinto's RIO.L project in Serbia has been hit by a Russian disinformation campaign.
- Hurricane Helene's devastating toll kept climbing on Sunday as search and rescue teams, combing through the wreckage of splintered homes and wind-tossed vehicles, counted at least 93 storm-related deaths across five states.
($1 = 7.0125 Chinese yuan renminbi)
(Compiled by Bengaluru newsroom)
</body></html>Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
